Abstract:Since the 1960s, efforts have been made to develop new technologies to eliminate the risk of thrombosis in medical devices that come into contact with blood. Preventing thrombosis resulting from the contact of a medical device, such as an implant, with blood is a challenge due to the high mortality rate of patients and the high cost of medical care. To this end, various types of biomaterials coated with polymer-drug layers are being designed to reduce their thrombogenicity and improve their hemocompatibility. This review presents the latest developments in the use of polymer-drug systems to produce anti-thrombogenic surfaces in medical devices in contact with blood, such as stents, catheters, blood pumps, heart valves, artificial lungs, blood vessels, blood oxygenators, and various types of tubing (such as for hemodialysis) as well as microfluidic devices. This paper presents research directions and potential clinical applications, emphasizing the importance of continued progress and innovation in the field.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop new technologies to eliminate the risk of thrombosis when medical devices (such as implants) come into contact with blood. Specifically, the authors focus on reducing the thrombogenicity of medical devices and improving their blood compatibility. By coating the surface of biomaterials with a polymer - drug layer, it aims to prevent thrombosis caused by the contact between medical devices and blood, thereby reducing the mortality rate of patients and medical costs. ### Summary of Main Problems 1. **Prevention of Thrombosis**: When medical devices (such as implants, stents, catheters, etc.) come into contact with blood, thrombosis is likely to be induced, which not only increases the patient's risk of death but also raises medical costs. Therefore, new technologies need to be developed to reduce this risk. 2. **Improvement of Blood Compatibility**: In order to ensure that medical devices do not cause adverse reactions (such as platelet activation, inflammation, etc.) when in contact with blood, it is necessary to improve the surface characteristics of these devices to make them more blood - compatible. 3. **Reduction of the Need for Systemic Treatment**: Currently, anticoagulant drugs or anti - platelet drugs are commonly used in clinical practice to prevent thrombosis, but these drugs will increase the risk of postoperative bleeding. Therefore, researchers hope to find local solutions to reduce the need for systemic drug treatment through surface modification. ### Solutions The paper proposes a method of coating the surface of medical devices with a polymer - drug layer to reduce thrombosis and improve blood compatibility. These coatings can release anticoagulant drugs or antibacterial drugs, inhibit blood coagulation or bacterial adhesion, and thus effectively prevent thrombosis and other adverse reactions. In addition, these coatings can also provide other functions, such as anti - corrosion, increased wear resistance, and improved biocompatibility. ### Application Areas This method is applicable to a variety of medical devices in contact with blood, such as: - Stents - Catheters - Blood pumps - Heart valves - Artificial lungs - Blood vessels - Blood oxygenators - Various pipelines (such as pipelines for dialysis) - Microfluidic devices In short, the core issue of this paper is to develop new medical devices that can reduce thrombosis and improve blood compatibility through surface modification techniques, thereby improving the treatment effect of patients and reducing medical costs.

Polymer-Drug Anti-Thrombogenic and Hemocompatible Coatings as Surface Modifications

PC Technology Improving the Hemocompatibility of Polymer Membranes Developed for Biomedical Application

Surface modification strategies for improved hemocompatibility of polymeric materials: a comprehensive review

Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis

Ultrathin and Robust Hydrogel Coatings on Cardiovascular Medical Devices to Mitigate Thromboembolic and Infectious Complications

Drug-free Antibacterial Polymers for Biomedical Applications

Unravelling Surface Modification Strategies for Preventing Medical Device‐Induced Thrombosis

Athrombogenic hydrogel coatings for medical devices--Examination of biological properties

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Surface modification of neurovascular stents: from bench to patient

Study of the Structure of Hyperbranched Polyglycerol Coatings and their Anti‐Biofouling and Anti‐Thrombotic Applications

Heparinized self-healing polymer coating with inflammation modulation for blood-contacting biomedical devices

An in Situ Grown Ultrathin and Robust Protein Nanocoating for Mitigating Thromboembolic Issues Associated with Cardiovascular Medical Devices.

Biopolymer Coating for Particle Surface Engineering and Their Biomedical Applications

Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity

Bioinspired zwitterionic microgel-based coating: Controllable microstructure, high stability, and anticoagulant properties

Recent developments in functional organic polymer coatings for biomedical applications in implanted devices

Antithrombogenic polysaccharide coatings to improve hemocompatibility, protein-repellence, and endothelial cell response

Incorporating Anticoagulant and Antiplatelet Dual Functional Groups into Thermosetting Polymer Chain for Enhancing Antithrombogenicity

Bioinspired ultra-low fouling coatings on medical devices to prevent device-associated infections and thrombosis

Anti-thrombogenic Surface Coatings for Extracorporeal Membrane Oxygenation: A Narrative Review